...
首页> 外文期刊>Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases >Prevalence and spread of extended-spectrum p-lactamase-producing Enterobacteriaceae in Europe
【24h】

Prevalence and spread of extended-spectrum p-lactamase-producing Enterobacteriaceae in Europe

机译:欧洲延长谱P-乳酰胺酶肠杆菌的患病率与传播

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Extended-spectrum beta-lactamases (ESBLs) represent a major threat among resistant bacterial isolates. The first types described were derivatives of the TEM-1, TEM-2 and SHV-1 enzymes during the 1980s in Europe, mainly in Klebsiella pneumoniae associated with nosocomial outbreaks. Nowadays, they are mostly found among Escherichia coli isolates in community-acquired infections, with an increasing occurrence of CTX-M enzymes. The prevalence of ESBLs in Europe is higher than in the USA but lower than in Asia and South America. However, important differences among European countries have been observed. Spread of mobile genetic elements, mainly epidemic plasmids, and the dispersion of specific clones have been responsible for the increase in ESBL-producing isolates, such as those with TEM-4, TEM-24, TEM-52, SHV-12, CTX-M-9, CTX-M-14, CTX-M-3, CTX-M-15 and CTX-M-32 enzymes.
机译:扩展光谱β-内酰胺酶(ESBLS)代表抗性细菌分离物之间的主要威胁。 所描述的第一种类型是TEM-1,TEM-2和SHV-1酶的衍生物在欧洲的20世纪80年代,主要是与医院爆发相关的Klebsiella肺炎。 如今,它们主要在群体获取的感染中的大肠杆菌分离物中发现,随着CTX-M酶的发生而增加。 ESBLS在欧洲的普遍率高于美国,但低于亚洲和南美洲。 但是,已经观察到欧洲国家的重要差异。 流动遗传元素的传播,主要是流行性质粒,以及特定克隆的分散对ESBL-产生的分离株的增加,例如TEM-4,TEM-24,TEM-52,SHV-12,CTX- M-9,CTX-M-14,CTX-M-3,CTX-M-15和CTX-M-32酶。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号